Hostname: page-component-8448b6f56d-m8qmq Total loading time: 0 Render date: 2024-04-24T09:53:35.619Z Has data issue: false hasContentIssue false
  • English
  • Français

Dual diagnosis in a Dublin tertiary addiction centre - A cross-sectional study

Published online by Cambridge University Press:  13 June 2014

Chinedu Iro  and
John O'Connor
Chinedu Iro*
Affiliation:
Kilkenny East Mental Health Service, Dept of Psychiatry, St Luke's Hospital, Kilkenny
John O'Connor
Affiliation:
Drug Treatment Centre Board, Trinity Court, 30-32 Pearse St, Dublin 2, Ireland
*
*Correspondence E-mail: ciro@dtcb.ie.
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives: To address the relative dearth of information relating to the prevalence of psychiatric co-morbidity among attenders of community addiction facilities.

Methods: We carried out a cross-sectional study of clients attending a Dublin-based tertiary addiction centre to assess the rates of psychiatric co-morbidity, determine the demographic and clinical variables and evaluate the level of contact with allied medical care especially primary care and community psychiatric services. Information was sourced from available patient records.

Results: Forty-three per cent of the clients (n = 59), attending the service were found to have a chart diagnosis of psychiatric disorder. Only 15% of these were in contact with community psychiatric services.

Conclusions: This high rate of psychiatric co-morbidity has implications in terms of funding, training and service delivery.

Keywords

Dual diagnosisCo-morbiditySubstance misuseAddictionIntegrated treatment
Type
Brief Reports
Information
Irish Journal of Psychological Medicine , Volume 26 , Issue 4 , December 2009 , pp. 191 - 193
Copyright
Copyright © Cambridge University Press 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Sciacca, KM, Thompson, CM. Programme Development and Integrated Treatment Across Systems for Dual Diagnosis: Mental Illness, Drug Addiction And Alcoholism, MIDAA*. J Mental Health Admin 1996; 23(3): 288–297.CrossRefGoogle ScholarPubMed
2.Abou-saleh, MT, Janca, A. The epidemiology of substance misuse and co-morbid psychiatric disorders. Acta Neuropsychiatrica 2004; 16: 3–8.CrossRefGoogle Scholar
3.Kessler, RC, McGonagle, KA, Zhao, S. Lifetime and 12 month prevalence of DSM-III R psychiatric disorders in the United States: Results from the National Co-morbidity Survey. Arch Gen Psychiatry 1994; 51: 8–19.CrossRefGoogle Scholar
4.Graham, HL, Maslin, J, Copello, Aet al.Drug and alcohol problems amongst individuals with severe mental health problems in an inner city area of the UK. Soc Psychiatry Psychiatr Epidemiol 2001; 36(9): 448–55.CrossRefGoogle Scholar
5.Kamali, M, Kelly, L, Gervin, M, Browne, S, Larkin, C, O'Callaghan, E. The prevalence of co-morbid substance misuse and its influence on suicidal ideation among in-patients with schizophrenia. Acta Psychiatr Scand 2000; 101 (6): 452–6CrossRefGoogle Scholar
6.Mueser, KT, Drake, RE, Wallach, MA. Dual diagnosis: a review of etiological theories. Addict Behav 1998; 23(6): 717–34.CrossRefGoogle ScholarPubMed
7.Wedekind, D, Jacobs, S, Karg, Iet al.Psychiatric co-morbidity and additional abuse of drugs in maintenance treatment with I- and d,l- methadone. World J Biol Psychiatry 2008; 29: 1–10.CrossRefGoogle Scholar
8.Drake, R, Mueser, KT. Psychosocial Approaches to Dual Diagnosis. Schizophr Bull 2000; 26(1): 105–118.CrossRefGoogle ScholarPubMed
9.Appleby, L, Shaw, J, Amos, T. Suicide within 12 months of contact with mental health services: National clinical survey. BMJ 1999; 318: 1235–1239.CrossRefGoogle ScholarPubMed
10.Safety First: Five Year Report of the National Confidential Inquiry Into Suicides and Homicide by People With Mental Illness. London: Department of Health. 2001.Google Scholar
11.Abou-saleh, MT. Dual Diagnosis: Management within a psychosocial context. Adv in Psychiatric Treatment 2004; 10: 352–360.CrossRefGoogle Scholar
12.Keenan, E. Irish addiction services – past, present and future. Ir J Psych Med 2005; 22(4): 118–120.CrossRefGoogle ScholarPubMed
13.Drake, RE, and Wallach, MA. Dual Diagnosis: 15 years of progress. Psychiatr Serv 2000; 51 (9): 1126–1129.CrossRefGoogle ScholarPubMed
14.National Advisory Committee on Drugs 2004. Mental Health and Addiction Services and the management of dual diagnosis in Ireland. Dublin: Stationary Office.Google Scholar
15. Substance Misuse Research: Co-morbid Mental Health and Substance Misuse in Scotland, [online]. Available from www.scotland.gov.uk/publications/2006/06/05104841/3 [Assessed 17th October 2007]Google Scholar
16.Crome, IB. Substance Misuse and Psychiatric Co-morbidity: towards improved service provision. Drugs: Education, Prevention and Policy 1999; 6: 151–174.Google Scholar
17.Drake, RE, Mercer-McFadden, C, Muesser, KTet al.Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophr Bull 1998; 24: 536–560.CrossRefGoogle ScholarPubMed
18.Farrell, M., Howes, S, Taylor, C, Lewis, G. Substance misuse and psychiatric co-morbidity: an overview of the OPCS National Psychiatric Morbidity Survey. Addict Behav 1998; 23: 909–918.CrossRefGoogle ScholarPubMed
19.Fowler, IL, Carr, VJ, Carter, NTet al.Patterns of Current and Lifetime Substance Use in Schizophrenia. Schizophr Bull 1998; 24: 443–455.CrossRefGoogle ScholarPubMed
20.Hall, W, Farrell, M. Co-morbidity of mental disorder with substance misuse. Br J Psychiatry 1997; 171: 4–5.CrossRefGoogle ScholarPubMed
21.Mueser, KT, Bellack, AS, Blanchard, JJ. Co-morbidity of schizophrenia and substance abuse: implications for treatment. J Consult Clinical Psychol 1992; 60: 845–856.CrossRefGoogle ScholarPubMed